SeaStar Medical Holding Corporation (ICU)
$3.59-6.75%Close
BUYRECOVERY · day 2
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $10M
- Beta
- -1.07
- P/E (TTM)
- -0.92
- Short % float
- 5.10%
- Days to cover
- 3.2
- SI change
- +18.1%
- 1W
- +12.54%
- 1M
- +16.94%
- vs SPY 1W
- +12.68%
- vs SPY 1M
- +14.43%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 3
- VALUE
- 7
- GROWTH
- 27
- GARP
- 2
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-97.7%
REV YoY-
ROE-162.8%
EPS YoY-
ROA-157.6%
GROSS93
OP-817
NET-796
[VALUATION]
P/E TTM-0.92
P/E FWD-
SECTOR PE20.34
INDUSTRY PE13.84
P/B3.41
P/FCF-
EV/EBITDA-0.32
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E-
ALTMAN Z-
CURR RATIO1.89
ND/EBITDA-
BETA-1.07
Company news
FAQ
- What is LOPJLB’s current signal on ICU?
- LOPJLB’s latest quantitative signal on SeaStar Medical Holding Corporation (ICU) is BUY in a RECOVERY regime. Signals are updated daily.
- What market regime is ICU in?
- SeaStar Medical Holding Corporation (ICU) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does SeaStar Medical Holding Corporation (ICU) do?
- SeaStar Medical Holding Corporation is a medical device company dedicated to providing innovative solutions and services designed to combat hyperinflammation and cytokine storm in critically ill individuals. The company specializes in developing and commercializing extracorporeal therapies that specifically target the immune 'effector cells' responsible for driving systemic inflammation, a proc…